Linde (LIN): Bearish Signals Point to Potential Put Plays

AI-powered insights updated on 11/4/2025.

AI Signal: Moderately Bearish outlook with weakening momentum.
LIN exhibits a confirmed downtrend with bearish technical indicators. Traders should monitor for downside continuation and potential Put opportunities.

Trend Strength

Below 50-day Moving Average

R S I Momentum

Weakening

Volume Surge

High volume confirms selling pressure

LIN Earnings Date & Key Events

Key upcoming dates for LIN that could impact its stock price.
DateEventType
12/3/2025LIN Dividend
LIN-Specific

Full Analysis Breakdown

About

Linde is the world's largest industrial gas company, producing and distributing atmospheric gases (oxygen, nitrogen, argon, and rare gases) and process gases (hydrogen, helium, carbon dioxide, carbon monoxide, electronic gases, specialty gases, and acetylene). It serves diverse industries, including healthcare, chemicals and energy, manufacturing, metals and mining, food and beverage, and electronics. Linde distributes its gases through on-site production, merchant (bulk liquid) deliveries, and packaged (cylinder) gases. The company also has an 'Engineering' business that designs and builds plants for gas production and processing, offering technologies for air separation, hydrogen, synthesis, olefin, and natural gas. Linde differentiates itself through its extensive process engineering expertise, sustainable technologies, and a comprehensive portfolio covering the entire value chain for hydrogen production.

News Summary

The short-term outlook for Linde (LIN) is slightly positive. Recent analyst activity presents a mixed but ultimately supportive picture. While both Citigroup and JP Morgan have maintained their respective 'Buy' and 'Overweight' ratings, they've also lowered their price targets to $520 and $455, respectively. This suggests some tempered expectations, potentially due to broader market conditions or sector-specific headwinds. However, Seaport Global's upgrade of Linde to 'Buy' with a $500 price target counteracts some of the negative sentiment. The upgrade indicates increased confidence in Linde's prospects. The price target revisions, while mixed, still suggest upside potential from current levels. Considering the upgrade and the overall positive (though slightly reduced) price targets, a mildly bullish outlook for LIN over the next 1-2 weeks is warranted. The stock's performance will likely be influenced by overall market sentiment and any further news related to the specialty chemicals sector.

Technicals

LIN's technical outlook is decidedly bearish. The stock is in a clear downtrend, closing at $417.91, significantly below its 50-day SMA of $464.13 and its 21-day EMA of $444.91, confirming strong negative momentum. The MACD at -11.87 signals substantial bearish momentum, with the MACD line far below the signal line. The RSI of 16.89 indicates oversold conditions, but in a strong downtrend, oversold readings can persist. The ADX is elevated at 39.87, suggesting a strong trend is in place, and in this case, it is downward. The Stochastics oscillator is also very low, further supporting the bearish view. The Bollinger Bands show the price is trading well below the lower band, indicating extreme selling pressure and potential for continued declines. The recent price action confirms the weakness, with a series of lower highs and lower lows. Given these strong bearish signals, the likelihood of continued downside pressure over the next 1-3 months is high.

Management Discussion

Linde's MD&A presents a generally positive but nuanced picture. 'Sales increased by 3% for the third quarter of 2025' to $8,615 million, driven by higher pricing and acquisitions. The 'cost of sales' decreased as a percentage of sales due to 'higher pricing and productivity gains'. Reported operating profit increased 13%, but adjusted operating profit only increased 3%, indicating that cost reduction programs and other charges impacted the reported figures. The reported effective tax rate decreased significantly, contributing to a '24% increase in net income' to $1,929 million for the quarter. Cash flow from operations increased 11% to $7,320 million for the nine months ended September 30, 2025, driven by higher net income and lower working capital requirements. Capital expenditures increased by $556 million to $3,803 million, reflecting investments in new plant and equipment. The company maintains sufficient liquidity with undrawn credit agreements of $6.5 billion and anticipates no limitations on accessing debt markets. Segment performance varied, with Americas and EMEA showing sales and operating profit increases, while APAC's operating profit decreased slightly. Engineering sales decreased due to project timing. Overall, the company is performing well, but the adjusted figures provide a more conservative view of the underlying operational improvements.

Earnings Call

Linde's Q2 2025 earnings call projects a moderately bullish outlook, balancing strong performance with economic uncertainties. CEO Sanjiv Lamba highlighted 'solid results' with EPS at $4.09 and an operating margin of 30.1%, both 'all-time quarterly highs.' The sales of gas project backlog has approximately doubled in a little over 4 years, from $3.6 billion to $7.1 billion. CFO Matt White provided Q3 guidance of $4.10 to $4.20 EPS, 4% to 7% above last year, and full-year guidance of $16.30 to $16.50, or 5% to 6% growth. While FX is expected to be a 1% tailwind, this is 'mostly offset...with a more negative assumption of the economy as the top end now assumes economic contraction.' Volume headwinds, primarily in EMEA, are attributed to contractual customers using less gas due to economic uncertainty, but management expects this 'to improve like it always has.' Despite these headwinds, Linde's disciplined capital allocation and access to low-cost capital support shareholder value creation, and management remains confident in returning to double-digit EPS growth.

Financials

LIN's financial performance over the past several quarters reveals a generally positive trajectory. Revenue has demonstrated growth, increasing from $8.1B in Q1 2024 to $8.615B in Q3 2025, indicating a healthy top-line expansion. The `grossProfitRatio` has fluctuated, but the income statement is showing a healthy net income with $1.929B in Q3 2025. Operating cash flow remains strong, with $2.948B reported in the most recent quarter. Total debt has risen slightly from $20.319B in Q1 2024 to $23.554B in Q3 2025. Overall, LIN demonstrates consistent profitability and cash generation, with manageable debt levels relative to its revenue and asset base. The company appears to be in a stable financial position, with a positive outlook for continued growth and profitability in the near term.

Fundamentals

The company presents a moderately bullish investment profile based on its financial data. Revenue has shown positive growth, indicating increasing market demand or successful market penetration. The gross margin is healthy, suggesting efficient cost management in production or service delivery. A strong return on equity (ROE) signals effective utilization of shareholder investments to generate profit. The price-to-earnings (P/E) ratio suggests the stock is trading at a premium, but this could be justified by the company's growth prospects and profitability. A manageable debt-to-equity ratio indicates a reasonable level of financial leverage. The current ratio, being greater than 1, demonstrates the company's ability to cover short-term liabilities with its current assets, further solidifying its financial health. Overall, the combination of revenue growth, healthy profitability metrics, and a solid balance sheet makes the company an attractive investment for the next 12 months, although the elevated P/E ratio warrants careful monitoring.

Unlock Data-Driven Options Setups
Go beyond static reports with an interactive dashboard
Access daily, top-rated Call & Put setups
Track performance for every signal we issue
Start Your Free 30-Day Trial
Disclaimer

The information provided on this page is for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice and you should not treat any of the page's content as such. ProfitScout does not recommend that any security should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions.

Related Stocks

    We Use Cookies

    We use cookies to enhance your experience, analyze site traffic, and for marketing purposes. By clicking "Accept," you agree to our use of cookies. Read our Privacy Policy.